Liver regeneration using decellularized splenic scaffold: a novel approach in tissue engineering.

BACKGROUND The potential application of decellularized liver scaffold for liver regeneration is limited by severe shortage of donor organs. Attempt of using heterograft scaffold is accompanied with high risks of zoonosis and immunological rejection. We proposed that the spleen, which procured more extensively than the liver, could be an ideal source of decellularized scaffold for liver regeneration. METHODS After harvested from donor rat, the spleen was processed by 12-hour freezing/thawing x 2 cycles, then circulation perfusion of 0.02% trypsin and 3% Triton X-100 sequentially through the splenic artery for 32 hours in total to prepare decellularized scaffold. The structure and component characteristics of the scaffold were determined by hematoxylin and eosin and immumohistochemical staining, scanning electron microscope, DNA detection, porosity measurement, biocompatibility and cytocompatibility test. Recellularization of scaffold by 5 x 10(6) bone marrow mesenchymal stem cells (BMSCs) was carried out to preliminarily evaluate the feasibility of liver regeneration by BMSCs reseeding and differentiation in decellularized splenic scaffold. RESULTS After decellularization, a translucent scaffold, which retained the gross shape of the spleen, was generated. Histological evaluation and residual DNA quantitation revealed the remaining of extracellular matrix without nucleus and cytoplasm residue. Immunohistochemical study proved the existence of collagens I, IV, fibronectin, laminin and elastin in decellularized splenic scaffold, which showed a similarity with decellularized liver. A scanning electron microscope presented the remaining three-dimensional porous structure of extracellular matrix and small blood vessels. The porosity of scaffold, aperture of 45.36 +/- 4.87 μm and pore rate of 80.14% +/- 2.99% was suitable for cell engraftment. Subcutaneous implantation of decellularized scaffold presented good histocompatibility, and recellularization of the splenic scaffold demonstrated that BMSCs could locate and survive in the decellularized matrix. CONCLUSION Considering the more extensive organ source and satisfying biocompatibility, the present study indicated that the three-dimensional decellularized splenic scaffold might have considerable potential for liver regeneration when combined with BMSCs reseeding and differentiation.

[1]  S. Badylak,et al.  XENOGENEIC EXTRACELLULAR MATRIX GRAFTS ELICIT A TH2-RESTRICTED IMMUNE RESPONSE1 , 2001, Transplantation.

[2]  A. Atala,et al.  Decellularization for whole organ bioengineering , 2013, Biomedical materials.

[3]  P. Krause,et al.  Acute impairment of hepatic microcirculation and recruitment of nonparenchymal cells by intrasplenic hepatocyte transplantation. , 2004, Journal of pediatric surgery.

[4]  Stephen F Badylak,et al.  A whole-organ regenerative medicine approach for liver replacement. , 2011, Tissue engineering. Part C, Methods.

[5]  Stephen F Badylak,et al.  Decellularization of tissues and organs. , 2006, Biomaterials.

[6]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[7]  Seok-Ho Hong,et al.  Preparation of immunogen-reduced and biocompatible extracellular matrices from porcine liver. , 2013, Journal of bioscience and bioengineering.

[8]  G. Vunjak‐Novakovic,et al.  Decellularization of human and porcine lung tissues for pulmonary tissue engineering. , 2013, The Annals of thoracic surgery.

[9]  Doris A Taylor,et al.  Decellularized tissue-engineered heart valve leaflets with recellularization potential. , 2013, Tissue engineering. Part A.

[10]  James J. Yoo,et al.  Tissue-engineered autologous bladders for patients needing cystoplasty , 2006, The Lancet.

[11]  Sara Mantero,et al.  Clinical transplantation of a tissue-engineered airway , 2008, The Lancet.

[12]  L. Brewster,et al.  Regeneration: letting the scaffold do the work. , 2013, The Journal of surgical research.

[13]  N. L'Heureux,et al.  Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.

[14]  H. Ijima,et al.  Solubilized matrix derived from decellularized liver as a growth factor-immobilizable scaffold for hepatocyte culture. , 2013, Journal of bioscience and bioengineering.

[15]  J. Guyette,et al.  Regeneration and Experimental Orthotopic Transplantation of a Bioengineered Kidney , 2013, Nature Medicine.

[16]  B. Christ,et al.  Human Bone Marrow Mesenchymal Stem Cell-Derived Hepatocytes Improve the Mouse Liver after Acute Acetaminophen Intoxication by Preventing Progress of Injury , 2014, International journal of molecular sciences.

[17]  Stephen F Badylak,et al.  The extracellular matrix as a biologic scaffold material. , 2007, Biomaterials.

[18]  Christian Schuetz,et al.  Regeneration and orthotopic transplantation of a bioartificial lung , 2010, Nature Medicine.

[19]  Stephen F Badylak,et al.  Immune response to biologic scaffold materials. , 2008, Seminars in Immunology.

[20]  J. Pober,et al.  Engraftment of a vascularized human skin equivalent , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Ning Zhang,et al.  The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. , 2012, Biomaterials.

[22]  Stephen F Badylak,et al.  An overview of tissue and whole organ decellularization processes. , 2011, Biomaterials.

[23]  Stephen F Badylak,et al.  RETRACTED: Engineered whole organs and complex tissues , 2012, The Lancet.

[24]  Y. Lv,et al.  Regeneration of splenic autotransplants attached on liver by a tissue adhesive. , 2010, Transplantation proceedings.

[25]  Peter G. Stock,et al.  OPTN/SRTR 2011 Annual Data Report: Liver , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  Hiroshi Yagi,et al.  Human-Scale Whole-Organ Bioengineering for Liver Transplantation: A Regenerative Medicine Approach , 2013, Cell transplantation.

[27]  Hiroshi Yagi,et al.  Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix , 2010, Nature Medicine.